Phase I trial of the combination of ibrutinib and lenalidomide of the treatment of patients with MDS who have failed standard therapy or who are unfit for or refuse standard therapy

Autor:	Samantha C. Fisch, Joseph M. Tuscano, Lihong Qi, Brian A. Jonas
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Leukemia Research. 122:106947
ISSN:	0145-2126
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::caa0d1471e3fba7619c9695c152fcb9f https://doi.org/10.1016/j.leukres.2022.106947 Zobrazit plný text záznamu Full Text from ScienceDirect